|
🐜
|
The gut microbiota and host health: a new clinical frontier
13 auth.
J. Marchesi,
D. Adams,
F. Fava,
Gerben D. A. Hermes,
G. Hirschfield,
G. Hold,
M. Quraishi,
J. Kinross,
H. Smidt,
K. Tuohy,
...
L. Thomas,
E. Zoetendal,
A. Hart
|
10 |
2015 |
10
🐜
|
|
🦁
|
Systematic review with meta‐analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection
7 auth.
M. Quraishi,
M. Widlak,
N. Bhala,
D. Moore,
M. Price,
Naveen Sharma,
...
T. Iqbal
|
8 |
2017 |
8
🦁
|
|
🐜
|
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
16 auth.
B. Mullish,
M. Quraishi,
J. Segal,
V. McCune,
M. Baxter,
G. Marsden,
D. Moore,
A. Colville,
N. Bhala,
T. Iqbal,
...
C. Settle,
G. Kontkowski,
A. Hart,
P. Hawkey,
S. Goldenberg,
H. Williams
|
8 |
2018 |
8
🐜
|
|
🦁
|
The gut-adherent microbiota of PSC–IBD is distinct to that of IBD
11 auth.
M. Quraishi,
M. Sergeant,
Gemma L. Kay,
T. Iqbal,
J. Chan,
C. Constantinidou,
...
P. Trivedi,
J. Ferguson,
D. Adams,
M. Pallen,
G. Hirschfield
|
7 |
2016 |
7
🦁
|
|
🐜
|
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic
25 auth.
G. Ianiro,
B. Mullish,
C. Kelly,
Z. Kassam,
E. Kuijper,
S. Ng,
T. Iqbal,
J. Allegretti,
S. Bibbò,
H. Sokol,
Faming Zhang,
M. Fischer,
S. Costello,
J. Keller,
L. Masucci,
...
J. van Prehn,
G. Quaranta,
M. Quraishi,
J. Segal,
D. Kao,
R. Satokari,
M. Sanguinetti,
H. Tilg,
A. Gasbarrini,
G. Cammarota
|
7 |
2020 |
7
🐜
|
|
🦁
|
A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways
14 auth.
M. Quraishi,
A. Acharjee,
A. Beggs,
Richard D Horniblow,
C. Tselepis,
Georgios Gkoutus,
Subrata Ghosh,
Amanda Rossiter,
N. Loman,
W. van Schaik,
...
D. Withers,
J. Walters,
G. Hirschfield,
T. Iqbal
|
6 |
2020 |
6
🦁
|
|
🐜
|
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.
16 auth.
B. Mullish,
M. Quraishi,
J. Segal,
V. McCune,
M. Baxter,
G. Marsden,
D. Moore,
A. Colville,
N. Bhala,
T. Iqbal,
...
C. Settle,
G. Kontkowski,
A. Hart,
P. Hawkey,
H. Williams,
S. Goldenberg
|
5 |
2018 |
5
🐜
|
|
🦁
|
Immunological mechanisms underpinning faecal microbiota transplantation for the treatment of inflammatory bowel disease
M. Quraishi,
W. Shaheen,
Ye Htun Oo,
Tariq Iqbal
|
5 |
2019 |
5
🦁
|
|
🐜
|
The application of omics techniques to understand the role of the gut microbiota in inflammatory bowel disease
8 auth.
J. Segal,
B. Mullish,
M. Quraishi,
A. Acharjee,
H. Williams,
T. Iqbal,
...
A. Hart,
J. Marchesi
|
5 |
2019 |
5
🐜
|
|
🐬
|
Gut microbiome and autoimmune disorders.
W. Shaheen,
M. Quraishi,
T. Iqbal
|
5 |
2022 |
5
🐬
|
|
🐬
|
Mechanisms underpinning the efficacy of faecal microbiota transplantation in treating gastrointestinal disease
J. Segal,
B. Mullish,
M. Quraishi,
T. Iqbal,
J. Marchesi,
H. Sokol
|
5 |
2020 |
5
🐬
|
